|
Home
Table B32a. Results (pg/g [pptr] wet weight)
of triplicate analyses for 2,3,7,8-substituted PCDD congeners in bluefish
muscle composites (Station BL1; nd = <MDL) |
Composite
# |
Congener |
2,3,7,8-
TCDD |
1,2,3,7,8-
PeCDD |
1,2,3,4,7,8-
HxCDD |
1,2,3,6,7,8-
HxCDD |
1,2,3,7,8,9-
HxCDD |
1,2,3,4,6,7,8-
HpCDD |
OCDD |
| 104 |
2.17 |
nd |
nd |
nd |
nd |
nd |
nd |
| 104-dup. |
2.44 |
nd |
nd |
nd |
nd |
nd |
nd |
| 104-trip. |
2.26 |
nd |
nd |
nd |
nd |
nd |
nd |
| Mean |
2.29 |
|
|
|
|
|
|
| Std. dev. |
0.14 |
|
|
|
|
|
|
| RSD (%) |
6.0 |
|
|
|
|
|
|
| |
| MDL |
1.6 |
7.3 |
3.1 |
3.4 |
11 |
6.5 |
4.0 |
Table B32b. Results (pg/g [pptr] wet weight) of
triplicate analyses for 2,3,7,8-substituted PCDF congeners in bluefish
muscle composites (Station BL1; nd = <MDL) |
Composite
# |
Congener |
2,3,7,8-
TCDFa |
1,2,3,7,8-
PeCDF |
2,3,4,7,8-
PeCDF |
1,2,3,4,7,8-
HxCDF |
1,2,3,6,7,8-
HxCDF |
1,2,3,7,8,9-
HxCDF |
2,3,4,6,7,8-
HxCDF |
1,2,3,4,6,7,8-
HpCDF |
1,2,3,4,7,8,9-
HpCDF |
OCDF |
| 104 |
2.18 |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
| 104-dup. |
2.44 |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
nd |
| 104-trip. |
1.90 |
nd |
|
|
|
|
|
|
|
|
| Mean |
2.17 |
|
|
|
|
|
|
|
|
|
| Std. dev. |
0.27 |
|
|
|
|
|
|
|
|
|
| RSD (%) |
12.4 |
|
|
|
|
|
|
|
|
|
| |
| MDL |
1.1 |
7.7 |
8.7 |
4.1 |
2.5 |
10 |
4.0 |
5.7 |
12 |
28 |
aValue for 2,3,7,8-TCDF in Batch 3 is taken
from "DB-Dioxin" second-column confirmation. |
Table B33
|